Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2002
[The current status of structured treatment interruption]Hirotomo Nakata, Hiroaki Mitsuya
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 5, 2024
Investigating the WHO's AWaRe classification for assessing antimicrobial stewardship programs: A single-center studyKazutaka Oda, Shinichiro Okamoto, Eisaku Iwanaga, et al.
Expert Opinion on Emerging Drugs|April 27, 2012
CCR5 inhibitors: emergence, success, and challengesKenji Maeda, Debananda Das, Hirotomo Nakata, et al.
Current Opinion in Pharmacology|September 8, 2004
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infectionKenji Maeda, Hirotomo Nakata, Hiromi Ogata, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 CapsidTravis Chia, Tomofumi Nakamura, Masayuki Amano, et al.
Hematology Reports|April 23, 2024
Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case ReportTomofumi Nakamura, Mitsuhiro Uchiba, Hirotomo Nakata, et al.
Journal of Virology|July 3, 2020
A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase InhibitorTomofumi Nakamura, Teruya Nakamura, Masayuki Amano, et al.
Pageof 4